CUT&RUN Decodes Drug Resistance Mechanisms
Beyond RNA-seq: Applying CUT&RUN to Decode Drug Resistance and Inform Rational Combination Therapies Key Takeaways: RNA-seq and ATAC-seq reveal transcriptional […]
Beyond RNA-seq: Applying CUT&RUN to Decode Drug Resistance and Inform Rational Combination Therapies Key Takeaways: RNA-seq and ATAC-seq reveal transcriptional […]
Fiber-seq Provides a More Complete View of the Human Brain Epigenome Fiber-seq: A Solution to Uncover Unmapped Epigenomic Regions Chromatin
Durham, NC – Oct. 16, 2025 (The Scientist) – Winning a spot in the 2025 Top Innovations contest’s Lab Research
Durham, NC – Sept. 3, 2025 (Life Science Newswire) – EpiCypher®, a pioneer in epigenomic research and technology, announces the
EpiCypher’s CUTANA™ CUT&RUN and CUT&Tag technologies are enabling major advancements in high-resolution profiling of histone post-translational modifications (PTMs) across scientific disciplines, including immunology, neuroscience,